Lijuan Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lijuan Xie has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Fengxu Gan
School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China
1 shared publication - Jianyu Zheng
School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China
1 shared publication - Jie Lou
School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China
1 shared publication - Junshan Lan
School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China
1 shared publication - Xiaofang Zhou
School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China
1 shared publication - Xing Zhou
Yunnan Key Laboratory of Stem Cell and Regenerative Medicine, Rehabilitation School, Kunming Medical University, Kunming, China
1 shared publication
Latest Publications
- Open Access
- 6 January 2025
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 16 (1) , 15
From Blood to Therapy: The Revolutionary Application of Platelets in Cancer-Targeted Drug Delivery
Biomimetic nanodrug delivery systems based on cell membranes have emerged as a promising approach for targeted cancer therapy due to their biocompatibility and low immunogenicity. Among them, platelet-mediated systems are particularly noteworthy for their innate tumor-homing and cancer cell interaction capabilities. These systems utilize nanoparticles shielded and directed by platelet membrane coatings for efficient drug delivery. This review highlights the role of platelets in cancer therapy, summarizes the advancements in platelet-based drug delivery systems, and discusses their integration with other cancer treatments. Additionally, it addresses the limitations and challenges of platelet-mediated drug delivery, offering insights into future developments in this innovative field.
- 6 January 2025
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 16 (1) , 15
Open AccessFrom Blood to Therapy: The Revolutionary Application of Platelets in Cancer-Targeted Drug Delivery
Biomimetic nanodrug delivery systems based on cell membranes have emerged as a promising approach for targeted cancer therapy due to their biocompatibility and low immunogenicity. Among them, platelet-mediated systems are particularly noteworthy for their innate tumor-homing and cancer cell interaction capabilities. These systems utilize nanoparticles shielded and directed by platelet membrane coatings for efficient drug delivery. This review highlights the role of platelets in cancer therapy, summarizes the advancements in platelet-based drug delivery systems, and discusses their integration with other cancer treatments. Additionally, it addresses the limitations and challenges of platelet-mediated drug delivery, offering insights into future developments in this innovative field.